ABT · News · 20260815N
Revenue Performance and Mix
ABBOTT LABORATORIES · 2026-08-15 · Importance 33 · Surprise 6 · In source text
Abbott Laboratories generated €37.74 billion of revenue over the last year, according to the reported segment breakdown. Medical Devices was the company’s largest segment at €18.21 billion. The United States was the largest geographic contributor, generating €14.58 billion. Abbott also reported quarterly revenue of $12.59 billion and EPS of $1.31, exceeding expectations.
Key facts
- In the last year, the company generated 37.74 billion EUR. source
- Medical Devices was the top-performing segment at 18.21 billion EUR. source
- Abbott Laboratories reported EPS of $1.31 and revenue of $12.59 billion. source
- QRG Capital Management Inc. reduced its stake in Abbott Laboratories by 28.7%, selling 83,416 shares and retaining 207,173 shares worth approximately $18.8 million. source
- Matrix Asset Advisors Inc. NY invested $4.29 million in Abbott Laboratories by acquiring 47,262 shares during the second quarter. source
- Institutional investors collectively own 75.18% of ABT. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | In the last year, the company generated 37.74 billion EUR. |
| revenue | positive | realized | — | Medical Devices was the top-performing segment at 18.21 billion EUR. |
| revenue | positive | realized | — | Abbott Laboratories reported EPS of $1.31 and revenue of $12.59 billion. |
| net_income | positive | realized | — | Abbott Laboratories reported EPS of $1.31 and revenue of $12.59 billion. |